This report analyzes the US Elastomer Infusion Pump market, examining growth drivers, trends, opportunities, and revenue projection from 2020 to 2035, highlighting major players such as Baxter International, B. Braun, and Fresenius Kabi.
The economic impact of tariffs on "US Elastomer Infusion Pump".
US Elastomer Infusion Pump Market Growth Drivers
Rise in Home-Based Healthcare and Ambulatory Care: With a surge in home-based healthcare and ambulatory infusion therapies post COVID-19, the demand for portable and user-friendly elastomer infusion pumps has increased. This shift is driven by hospitals minimizing patient admissions and focusing on outpatient solutions. Companies like Baxter International have expanded their elastomer pump portfolios to target homecare, providing reliable and patient-friendly devices that support both oncology and pain management treatments in home settings.
Increasing Prevalence of Chronic Diseases: The growing incidence of chronic diseases such as cancer and diabetes requires consistent long-term medication infusions. As a result, elastomer infusion pumps have seen a significant uptick in sales due to their accuracy, security, and cost-effectiveness. B. Braun has recently emphasized R&D investments, developing pumps featured for chemotherapy and antibiotic administration for chronic disease management, reinforcing their market presence.
US Elastomer Infusion Pump Market Trends
Integration of Smart Monitoring Features: Companies are increasingly integrating smart monitoring functionalities into elastomer infusion pumps, enhancing their safety profile and data connectivity. For instance, Fresenius Kabi has initiated projects to incorporate passive monitoring features that notify caregivers about the completion of infusion cycles. This trend is pivotal as providers seek better compliance and real-time dosage tracking, aligning with digital health initiatives.
Shift Towards Biodegradable and Eco-friendly Pump Materials: There is a notable trend towards developing eco-friendly elastomer infusion pumps using biodegradable materials, minimizing environmental impact. Baxter International recently launched pumps using partially recyclable polymers, reflecting the healthcare industry's response to sustainability concerns. This innovation is expected to influence procurement decisions among healthcare providers, especially those with green initiatives.
US Elastomer Infusion Pump Market Opportunities
Expansion in Post-Surgical Pain Management: With enhanced recovery protocols becoming standard, there is a growing opportunity for elastomer infusion pumps in post-surgical pain management, reducing opioid utilization. B. Braun has begun pilot projects in orthopedic clinics to deploy their pumps for local anesthetic delivery post-surgery.
Growth in Pediatric and Geriatric Applications: The increasing focus on pediatric and geriatric patient populations, who benefit from precise low-volume infusions, presents a significant untapped market. Companies like Baxter are tailoring elastomer pump designs to meet the unique needs of these groups.
US Elastomer Infusion Pump Market Revenue (USD Million), 2020-2035
The US elastomer infusion pump market exhibited steady growth from 2020 to 2025, rising from USD 320 million in 2020 to USD 445 million in 2025, driven by expansion in homecare and chronic disease treatment. Continued advancements and expanded applications in oncology and post-surgical care are projected to push the market to USD 900 million by 2035 at a CAGR of approximately 7.1%. This sustained growth reflects increasing adoption, innovation in product features, and emerging opportunities in new patient demographics.
US Elastomer Infusion Pump Market by Regions Share (%), 2025
In 2025, the Northeast region holds the largest market share for elastomer infusion pumps, accounting for 35%, due to its high concentration of hospitals and advanced healthcare facilities. The Midwest follows with 22%, supported by a network of specialty clinics and home infusion providers. The South’s share stands at 20%, reflecting growing adoption in states prioritizing outpatient care. The West captures 18%, driven by robust cancer care infrastructure, while other regions collectively account for 5%. This regional distribution highlights the influence of healthcare infrastructure and demographics on market penetration.
US Elastomer Infusion Pump Recent Developments
In April 2024, Baxter International announced FDA clearance of their next-generation elastomer infusion pump, which features enhanced accuracy and an intuitive user interface, targeting improved outcomes in home-based oncology and pain care. The product launch aims to expand their presence in ambulatory care markets and meet rising demand for patient-friendly infusion solutions.
In March 2024, B. Braun published results from a multicenter clinical study demonstrating reduced rates of postoperative infections using their elastomeric pumps for antibiotic infusion in orthopedic surgeries. The findings have prompted several leading hospital systems to expand contracts with B. Braun, further cementing the company’s leadership in the segment.
In January 2024, Fresenius Kabi entered a strategic partnership with a major telehealth platform to provide integrated elastomer infusion pump monitoring for remote cancer care. The collaboration will roll out in select US regions, offering real-time infusion data synchronization for enhanced patient support and adherence monitoring.
Press Releases